Chapman PB - Search Results

1

Horvat TZ, Adel NG, Dang TO, Momtaz P, Postow MA, Callahan MK, Carvajal RD, Dickson MA, D'Angelo SP, Woo KM, Panageas KS, Wolchok JD, Chapman PB. Horvat TZ, et al. Among authors: chapman pb. J Clin Oncol. 2016 Mar 20;34(9):1018-9. doi: 10.1200/JCO.2015.65.7007. Epub 2016 Jan 19. J Clin Oncol. 2016. PMID: 26786917 No abstract available.

2

Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.

Chapman PB, Lester TJ, Casper ES, Gabrilove JL, Wong GY, Kempin SJ, Gold PJ, Welt S, Warren RS, Starnes HF, et al. Chapman PB, et al. J Clin Oncol. 1987 Dec;5(12):1942-51. doi: 10.1200/JCO.1987.5.12.1942. J Clin Oncol. 1987. PMID: 3681377

3

Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies.

Yao TJ, Meyers M, Livingston PO, Houghton AN, Chapman PB. Yao TJ, et al. Among authors: chapman pb. Clin Cancer Res. 1999 Jan;5(1):77-81. Clin Cancer Res. 1999. PMID: 9918205 Clinical Trial.

4

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM. Chapman PB, et al. J Clin Oncol. 1999 Sep;17(9):2745-51. doi: 10.1200/JCO.1999.17.9.2745. J Clin Oncol. 1999. PMID: 10561349 Clinical Trial.

5

Intradermal injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells.

Nasi ML, Lieberman P, Busam KJ, Prieto V, Panageas KS, Lewis JJ, Houghton AN, Chapman PB. Nasi ML, et al. Among authors: chapman pb. Cytokines Cell Mol Ther. 1999 Sep;5(3):139-44. Cytokines Cell Mol Ther. 1999. PMID: 10641571 Clinical Trial.

6

Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.

Chapman PB, Morrissey DM, Panageas KS, Hamilton WB, Zhan C, Destro AN, Williams L, Israel RJ, Livingston PO. Chapman PB, et al. Clin Cancer Res. 2000 Mar;6(3):874-9. Clin Cancer Res. 2000. PMID: 10741710 Clinical Trial.

7

Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy.

Wolchok JD, Klimek VM, Williams L, Chapman PB. Wolchok JD, et al. Among authors: chapman pb. Cytokines Cell Mol Ther. 1999 Dec;5(4):205-6. Cytokines Cell Mol Ther. 1999. PMID: 10850383

8

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide.

Lewis JJ, Janetzki S, Schaed S, Panageas KS, Wang S, Williams L, Meyers M, Butterworth L, Livingston PO, Chapman PB, Houghton AN. Lewis JJ, et al. Among authors: chapman pb. Int J Cancer. 2000 Aug 1;87(3):391-8. doi: 10.1002/1097-0215(20000801)87:3<391::aid-ijc13>3.0.co;2-k. Int J Cancer. 2000. PMID: 10897045 Clinical Trial.

9

Systemic chemotherapy.

Klimek VM, Wolchok JD, Chapman PB, Houghton AN, Hwu WJ. Klimek VM, et al. Among authors: chapman pb. Clin Plast Surg. 2000 Jul;27(3):451-61, ix-x. Clin Plast Surg. 2000. PMID: 10941565 Review.

10

Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine: a trial comparing doses of G(D2)-keyhole limpet hemocyanin.

Chapman PB, Morrisey D, Panageas KS, Williams L, Lewis JJ, Israel RJ, Hamilton WB, Livingston PO. Chapman PB, et al. Clin Cancer Res. 2000 Dec;6(12):4658-62. Clin Cancer Res. 2000. PMID: 11156217 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters